SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
APLIF (MC $65 M) Covid 19 Phase 3 data Next Month =10 Bagger
An SI Board Since February 2021
Posts SubjectMarks Bans Symbol
1 1 0 APLIF
Emcee:  BioHero Type:  Moderated
Introduction Market Data Compact
Very low valuation of $65 million ,well financed with $ 20 million and BIG milestones is aorund the corner with the Phase 3 readout of the Covid 19 program and potential approval of the drug in Canada. They expect to submit 2 NDA´s during the year including the covid 19 treatment . This under radar stock has potential to run to $10 and even higher .STRONG BUY

Presentation
7343a5f0-1b48-4477-8577-969ff9b4ed06.filesusr.com

Adding to the COVID-19 treatment toolbox
thechronicleherald.ca
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News